-
1
Nucleic Acid-Based Therapy Approaches for Huntington's Disease
Published 2012-01-01“…Huntington's disease (HD) is caused by a dominant mutation that results in an unstable expansion of a CAG repeat in the huntingtin gene leading to a toxic gain of function in huntingtin protein which causes massive neurodegeneration mainly in the striatum and clinical symptoms associated with the disease. …”
Get full text
Article -
2
The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
Published 2025-01-01“…Huntington’s disease (HD) is primarily caused by the aberrant aggregation of the N-terminal exon 1 fragment of mutant huntingtin protein (mHttex1) with expanded polyglutamine (polyQ) repeats in neurons. …”
Get full text
Article -
3
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.
Published 2017-01-01“…Peripheral treatment with ASOs led to persistent reduction of huntingtin protein in peripheral organs, including liver (64% knockdown), brown adipose (66% knockdown), and white adipose tissues (71% knockdown). …”
Get full text
Article -
4
Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease
Published 2024-12-01“…Abstract Neurodegeneration in Huntington’s disease (HD) is accompanied by the aggregation of fragments of the mutant huntingtin protein, a biomarker of disease progression. …”
Get full text
Article -
5
Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease
Published 2025-02-01“…Huntington's disease (HD) is caused by the expansion of a CAG repeat, encoding a string of glutamines (polyQ) in the first exon of the huntingtin gene (HTTex1). This mutant huntingtin protein (mHTT) with extended polyQ forms aggregates in cortical and striatal neurons, causing cell damage and death. …”
Get full text
Article